J-STAR Research, Inc.
J-STAR Research, Inc., a leading name in the biotechnology sector, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2010, the company has established itself as a pioneer in advanced research and development, focusing on innovative solutions in drug discovery and development. J-STAR Research offers a unique portfolio of services, including high-throughput screening, assay development, and custom synthesis, tailored to meet the specific needs of pharmaceutical and biotech clients. Their commitment to cutting-edge technology and scientific excellence has positioned them as a trusted partner in the industry. With a reputation for delivering high-quality results and a strong emphasis on collaboration, J-STAR Research has achieved notable milestones, including partnerships with leading academic institutions and successful contributions to numerous drug development projects.
DitchCarbon Score
How does J-STAR Research, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
J-STAR Research, Inc.'s score of 48 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
J-STAR Research, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Porton Pharma Solutions Ltd., which may influence its climate commitments and reporting practices. As part of its corporate family relationship, J-STAR Research, Inc. inherits climate initiatives and targets from Porton Pharma Solutions Ltd. However, there are no documented reduction targets or climate pledges available for J-STAR Research, Inc. at this time. This lack of specific data suggests that the company may still be in the process of establishing its own emissions reduction strategies or aligning with broader corporate sustainability goals set by its parent organisation. In summary, while J-STAR Research, Inc. does not currently provide emissions data or specific climate commitments, it is positioned within a corporate structure that may guide its future environmental initiatives through the practices of Porton Pharma Solutions Ltd.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 26,761,250 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 67,599,610 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
J-STAR Research, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
